Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 75,561 shares of the company's stock, valued at approximately $557,000. Point72 Asia Singapore Pte. Ltd. owned approximately 0.15% of Nu Skin Enterprises as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of NUS. Public Employees Retirement System of Ohio lifted its position in Nu Skin Enterprises by 30.5% in the first quarter. Public Employees Retirement System of Ohio now owns 3,926 shares of the company's stock valued at $54,000 after purchasing an additional 918 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in Nu Skin Enterprises by 6.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 19,262 shares of the company's stock worth $203,000 after purchasing an additional 1,096 shares during the period. SummerHaven Investment Management LLC increased its position in Nu Skin Enterprises by 4.7% during the second quarter. SummerHaven Investment Management LLC now owns 25,778 shares of the company's stock valued at $272,000 after acquiring an additional 1,152 shares during the last quarter. Signaturefd LLC increased its holdings in Nu Skin Enterprises by 72.6% during the second quarter. Signaturefd LLC now owns 3,797 shares of the company's stock valued at $40,000 after buying an additional 1,597 shares during the last quarter. Finally, Ensign Peak Advisors Inc grew its holdings in Nu Skin Enterprises by 9.0% during the second quarter. Ensign Peak Advisors Inc now owns 19,976 shares of the company's stock valued at $211,000 after purchasing an additional 1,650 shares during the period. 82.84% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. StockNews.com upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, November 11th. Citigroup lowered their target price on Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating for the company in a report on Tuesday, October 22nd. Finally, DA Davidson decreased their target price on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a "neutral" rating for the company in a research report on Monday, August 12th.
Check Out Our Latest Research Report on Nu Skin Enterprises
Nu Skin Enterprises Stock Performance
NUS stock traded down $0.13 during midday trading on Tuesday, reaching $7.50. The stock had a trading volume of 592,948 shares, compared to its average volume of 848,891. The firm has a fifty day simple moving average of $6.79 and a two-hundred day simple moving average of $9.22. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93. The stock has a market cap of $372.83 million, a PE ratio of -3.62 and a beta of 1.20. Nu Skin Enterprises, Inc. has a 52-week low of $5.95 and a 52-week high of $20.75.
Nu Skin Enterprises Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th will be paid a $0.06 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.20%. Nu Skin Enterprises's payout ratio is currently -11.59%.
Nu Skin Enterprises Company Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.